(2-Aminoethyl)trimethylammonium chloride hydrochloride, 98%, 1g

1-METHYL-6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-3,4-DIHYDROQUINOLIN-2(1H)-ONE, 95.0%, 1g

2-Bromobenzimidazole>98.0%(GC)(T)1g

Umifenovir, 98%, 25g

4-(CYCLOHEXYLMETHYLAMINO)-2-(METHYLTHIO)PYRIMIDINE-5-CARBOXYLIC ACID, 95.0%, 250mg

1-(3-Nitropyridin-2-yl)piperidine-4-carboxylic acid, 100mg

2-Fluorobenzyl bromide, 98.0%, 25g

2-Bromo-4-chlorobenzoic acid, 97.0%, 1g

iScope IS.1153-EPL/DF Triocular with E-plan objectives and Rackless cross table (dark field contrast application)

2-Amino-4-chlorothiazole-5-carboxaldehyde, 95.0%, 10g

Benzyl (S)-2-(5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoate hydrochloride, 98%, 250mg

tert-Butyl 3,6-diazabicyclo[3.1.0]hexane-3-carboxylate, 95.0%, 1g

(2-Pyridyl)thiourea>98.0%(HPLC)(T)25g